References
- Chung, S. A., and P. Seo. 2010. Microscopic polyangiitis. Rheum. Dis. Clin. North Am. 36: 545–558
- Villiger, P. M., and L. Guillevin. 2010. Microscopic polyangiitis. Clinical presentation. Autoimmun. Rev. 9: 812–819
- Kallenberg, C. G., P. Heeringa, and C. A. Stegeman. 2006. Mechanisms of disease pathogenesis and treatment of ANCA-associated vasculitides. Nat. Clin. Pract. Rheumatol. 2: 661–670
- Guilpain, P., A. Servettaz, C. Goulvestre, et al. 2007. Pathogenic effects of antimyeloperoxidase antibodies in patients with microscopic polyangiitis. Arthritis Rheum. 56: 2455–2463
- Mulder, A. H., P. Heeringa, E. Brouwer, et al. 1994. Activation of granulocytes by anti-neutrophil cytoplasmic antibodies (ANCA): a FcgRII-dependent process. Clin. Exp. Immunol. 98: 270--278
- Falk, R. J., and G. S. Hoffman. 2007. Controversies in small vessel vasculitis-comparing the rheumatology and nephrology views. Curr. Opin. Rheumatol. 19: 1–9
- Kobayashi, S., A. Ito, D. Okuzaki, et al. 2012. Ficolin 1 expression is elevated in the peripheral blood mononuclear cells of Takayasu's vasculitis patients. J. Mol. Biomark. Diagn. 2: 125
- Borke, M. E., M. U. Nwagu, D. Obaseki, and N. O. Bazuaye. 2010. Churg--Strauss syndrome: a review. Niger. J. Med. 19: 136–139
- Vaglio, A., F. Moosig, and J. Zwerina. 2012. Churg--Strauss syndrome: update on pathophysiology and treatment. Curr. Opin. Rheumatol. 24: 24–30
- Tougan, T., H. Onda, D. Okuzaki, et al. 2008. Focused microarray analysis of peripheral mononuclear blood cells from Churg--Strauss syndrome patients. DNA Res. 15: 103–114
- Deng, Y., and B. P. Tsao. 2010. Genetic susceptibility to systemic lupus erythematosus in the genomic era. Nat. Rev. Rheumatol. 6: 683–692
- Dhople, V., A. Krukemeyer, and A. Ramamoorthy. 2006. The human beta-defensin-3, an antibacterial peptide with multiple biological functions. Biochim. Biophys. Acta. 1758: 1499–1512
- Ishii, T., H. Onda, A. Tanigawa, et al. 2005. Isolation and expression profiling of genes up-regulated in the peripheral blood cells of systemic lupus erythematosus patients. DNA Res. 12: 429–439
- Provan, D. 2009. Characteristics of immune thrombocytopenic purpura: a guide for clinical practice. Eur. J. Haematol. Suppl. 71: 8–12
- Nakamura, N., Y. Shimaoka, T. Tougan, et al. 2006. Isolation and expression profiling of genes up-regulated in bone marrow-derived mononuclear cells of rheumatoid arthritis patients. DNA Res. 13: 169–183
- Chen, M., M. R. Daha, and C. G. Kallenberg. 2010. The complement system in systemic autoimmune disease. J. Autoimmun. 34: J276–286
- Vernon, K. A., and H. T. Cook. 2012. Complement in glomerular disease. Adv. Chronic. Kidney Dis. 19: 84–92
- Thurman, J. M. 2012. Therapeutic regulation of complement in patients with renal disease—where is the promise? Clin. Nephrol. 77: 413–423
- Yuan, J., S. J. Gou, J. Huang, et al. 2012. C5a and its receptors in human anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis. Arthritis. Res. Ther. 14: R140
- Garred, P., C. Honoré, Y. J. Ma, et al. 2010. The genetics of ficolins. J. Innate. Immun. 2: 3–16
- Garred, P., C. Honoré, Y. J. Ma, et al. 2009. MBL2. FCN1. FCN2 and FCN3 -- The genes behind the initiation of the lectin pathway of complement. Mol. Immunol. 46: 2737–2744
- Hummelshøj, T., J. Nissen, L. Munthe-Fog, et al. 2011. Allelic lineages of the ficolin genes (FCNs) are passed from ancestral to descendant primates. PLoS One 6: e28187
- Mason, J. C. 2010. Takayasu arteritis – advances in diagnosis and management. Nat. Rev. Rheumatol. 6: 406–415
- Jennette, J. C., R. J. Falk, K. Andrassy, et al. 1994. Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum. 37: 187–192
- Joh, K., E. Muso, H. Shigematsu, et al. 2008. Renal pathology of ANCA-related vasculitis: proposal for standardization of pathological diagnosis in Japan. Clin. Exp. Nephrol. 12: 277–291
- Ito, A., M. Okada, K. Uchino, et al. 2003. Expression of the TSLC1 adhesion molecule in pulmonary epithelium and its down-regulation in pulmonary adenocarcinoma other than bronchioloalveolar carcinoma. Lab. Invest. 83: 1175–1183
- Tong, Y., W. Tempel, H. Wang, et al. 2010. Phosphorylation-independent dual-site binding of the FHA domain of KIF13 mediates phosphoinositide transport via centaurin alpha1. Proc. Natl. Acad. Sci. U S A. 107: 20346--20351
- Kawai, T., and S. Akira. 2011. Toll-like receptors and their crosstalk with other innate receptors in infection and immunity. Immunity 34: 637–650
- Hall, J. C., and A. Rosen. 2010. Type I interferons: crucial participants in disease amplification in autoimmunity. Nat. Rev. Rheumatol. 6: 40–49
- Cartin-Ceba, R., T. Peikert, and U. Specks. 2012. Pathogenesis of ANCA-associated vasculitis. Curr. Rheumatol. Rep. 14: 48–493
- Savige, J., W. Pollock, and M. Trevisin. 2005. What do antineutrophil cytoplasmic antibodies (ANCA) tell us? Best. Pract. Res. Clin. Rheumatol. 19: 263–276
- Okuzaki, D., T. Fukushima, T. Tougan, et al. 2010. Genopal TM: a novel hollow fiber array for focused microarray analysis. DNA Res. 17: 369–379
- Okuzaki, D., S. Kimura, N. Yabuta, et al. 2011. LeukoCatch, a quick and efficient tool for the preparation of leukocyte extracts from blood. BMC Clin. Pathol. 11: 9
- Okamoto, A., K. Torigata, M. A. Sakurai, et al. 2012. A simple and efficient method for the preparation of live leukocytes from peripheral blood using the LeukoCatchTM system. Adv. Biosci. Biotech. 3: 630–642
- Gou, S. J., J. Yuan, M. Chen, et al. 2013. Circulating complement activation in patients with anti-neutrophil cytoplasmic antibody-associated vasculitis. Kidney Int. 83: 129–137